NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/05/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.17 mln
Float4.46 mln
Earnings Date06/26/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
24
/ 100
Significantly lagging
Debt / Equity
0.15
Very low leverage
ROE
-4.10
Negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Aptorum Group Limited is a UK-based medical company focused on researching and developing treatments for cancer, bacterial infections, and other serious health conditions. The company is currently running clinical trials for several drug candidates, including treatments for neuroblastoma, tuberculosis, and staphylococcus aureus infections, while also exploring early-stage therapies for conditions such as endometriosis, obesity, and autoimmune disease. Beyond its drug pipeline, Aptorum offers a dietary supplement designed for women going through menopause and provides management services.
